Improving Aniridia Diagnosis with MLPA
Author Information
Author(s): Egbert J.W. Redeker, Annette S.H. de Visser, Arthur A.B. Bergen, Marcel M.A.M. Mannens
Primary Institution: Academic Medical Centre, University of Amsterdam
Hypothesis
Can multiplex ligation-dependent probe amplification (MLPA) enhance the molecular diagnosis of aniridia?
Conclusion
MLPA significantly improves the detection of mutations in the PAX6 gene associated with aniridia.
Supporting Evidence
- 24 different point mutations in the PAX6 gene were identified in 34 patients.
- Eight additional patients had deletions detected using MLPA.
- The mutation detection rate increased from 49% to 60% with MLPA.
Takeaway
This study shows that a special test called MLPA can help doctors find more genetic problems in people with a condition called aniridia, which affects their eyes.
Methodology
Total genomic DNA was isolated from peripheral blood, followed by PCR and MLPA to identify mutations in the PAX6 gene.
Limitations
40% of patients did not receive a molecular diagnosis, possibly due to misdiagnosis or undetected mutations in non-coding regions.
Participant Demographics
70 unrelated patients with isolated aniridia.
Want to read the original?
Access the complete publication on the publisher's website